Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON42683
NL-OMON42683CompletedNot Applicable

A Randomized, Double-Blind, Crossover, Comparative Pharmacokinetic Trial of Deulevodopa (TEV-50939) and Levodopa, both Administered with Carbidopa in Healthy Subjects - TEV-50939 and Levodopa comparative study

Teva Pharmaceuticals International GmbH0 sites16 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
16
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • •healthy male or female subjects
  • •- 25-40 yrs, inclusive
  • •- BMI: 18.5-30.0 kg/m2, inclusive

Exclusion Criteria

  • •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.

Investigators

Similar Trials

Completed
Phase 3
A clinical trial comparing bronchodilator effects of two drugs,Tiotropium Bromide and Formoterol Fumarate each over 24 hours in subjects with Asthma.
CTRI/2008/091/000306Chest Research Foundation30
Completed
Phase 1
A Study to Evaluate the Safety and Pharmacokinetics of Bevacizumab After a Single Dose in Healthy MalesCervical (cervix) cancerOvarian or primary peritoneal cancerRenal cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Lung - Non small cellCancer - Cervical (cervix)Cancer - Ovarian and primary peritonealCancer - KidneyCancer - BrainCancer - BreastBreast CancerGlioblastomaNon-small cell lung cancerColorectal cancer
ACTRN12619001287123Syneos Health New Zealand Limited111
Recruiting
Phase 4
A Comparative Phase-IV Clinical Trial for the treatment of acute painful musculospastic conditions using Oral Tablets of Fixed-dose Combination of Aceclofenac 100/100 mg, Paracetamol 325/325 mg and Thiocolchicoside 4/8 mg in comparison with Aceclofenac 100/100 mg and Thiocolchicoside 4/8 mg.
CTRI/2020/06/025614Akums Drugs and Pharmaceuticals Limited
Not yet recruiting
Not Applicable
In patients suffering from acute or chronic Rhino-sinusitis
CTRI/2017/03/008016VITROBIO63
Not yet recruiting
Not Applicable
Clinical Trial Study to Evaluate Efficacy and Safety of a Filmogen Glycerol Throat Spray containing CW-CYANIDIN Plant Premix
CTRI/2016/09/007265VITROBIO63